Antibody-drug conjugates key to Pfizer’s Seagen acquisition Finances April 1, 2023 [ad_1] Love Worker Pfizer’s (NYSE:PFE) acquisition of Seagen (NASDAQ:SGEN), introduced in March, is predicted to enhance the pharma big’s present…
Manhattan BioSolutions, Inc. Signs Commercial Evaluation License Agreements with the National Institutes of Health (NIH) for Use of Monoclonal Antibodies in Novel Antibody-Drug Conjugate (ADC) Oncology Programs Markets July 20, 2022 [ad_1] NEW YORK, NY / ACCESSWIRE / July 20, 2022 / Manhattan BioSolutions, Inc. at this time introduced it has…
